Vimarsana
Biggest News Aggregation in the World

Page 16 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Designation Today - Breaking & Trending Today

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion - Vimarsana News

Theradaptive Secures Third FDA Breakthrough Designation for Spinal Fusion

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System - Vimarsana News

Carthera receives FDA Breakthrough Device Designation for SonoCloud-9 System

Breakthrough Status allows for enhanced interaction with FDA and recognizes SonoCloud system as innovative and promising approach for treatment of recurrent glioblastoma Paris, France, June 22, 2022 – Carthera, a French company that designs and develops SonoCloud, an innovative ultrasound-based medical device to tre...

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil - Vimarsana News

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil 13-Jun-2022 /

Week in review: Zhaoke signs $130 million deal for vision-improving eyedrops - Vimarsana News

Week in review: Zhaoke signs $130 million deal for vision-improving eyedrops

Zhaoke Ophthalmology of Hong Kong acquired China/Southeast Asia rights for two eyedrop candidates designed to improve near vision from Seattle’s Visus Therapeutics in a $130 million deal.